Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Purchased by Phocas Financial Corp.

Phocas Financial Corp. increased its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 36.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 72,225 shares of the company's stock after purchasing an additional 19,123 shares during the period. Phocas Financial Corp. owned 0.08% of Acadia Healthcare worth $4,580,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the company. LMR Partners LLP purchased a new stake in shares of Acadia Healthcare in the 3rd quarter valued at about $1,616,000. Vaughan Nelson Investment Management L.P. increased its position in Acadia Healthcare by 4.8% in the 3rd quarter. Vaughan Nelson Investment Management L.P. now owns 768,940 shares of the company's stock valued at $48,758,000 after acquiring an additional 35,435 shares during the period. Natixis Advisors LLC raised its stake in Acadia Healthcare by 10.3% during the 3rd quarter. Natixis Advisors LLC now owns 193,989 shares of the company's stock valued at $12,301,000 after acquiring an additional 18,094 shares during the last quarter. Sivik Global Healthcare LLC raised its stake in Acadia Healthcare by 43.7% during the 3rd quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company's stock valued at $7,292,000 after acquiring an additional 34,997 shares during the last quarter. Finally, Zions Bancorporation N.A. purchased a new stake in Acadia Healthcare during the 3rd quarter valued at approximately $828,000.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They set a "sector weight" rating on the stock. Cantor Fitzgerald restated a "neutral" rating and issued a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft upped their target price on Acadia Healthcare from $70.00 to $75.00 and gave the company a "hold" rating in a report on Friday, August 2nd. Royal Bank of Canada decreased their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating on the stock in a research report on Monday. Finally, StockNews.com upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, November 14th. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and an average price target of $83.33.

Acadia Healthcare Stock Up 0.4 %

NASDAQ ACHC traded up $0.13 during trading hours on Tuesday, hitting $37.26. The company had a trading volume of 790,422 shares, compared to its average volume of 1,003,540. The firm's 50 day moving average is $57.27 and its 200 day moving average is $65.34. The company has a market capitalization of $3.46 billion, a price-to-earnings ratio of 12.17, a P/E/G ratio of 1.68 and a beta of 1.33. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 EPS. Sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.